PER 7.50% 8.6¢ percheron therapeutics limited

ann: atl 1102 trial commencement, page-17

  1. 110 Posts.
    Looks like phase 1 they previously tested doses in humans up to 18mg/kg/week which would work out equivalent to the 400mg daily dose 3 times for a week.

    I also read they had previously done animal tox studies prior to phase 1 as you would expect and obviously was ok to proceed to test in humans.

    Adds to the mystery of how Teva saw anything negative from their tox study...
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢
Change
0.006(7.50%)
Mkt cap ! $89.16M
Open High Low Value Volume
8.3¢ 8.9¢ 8.1¢ $294.9K 3.491M

Buyers (Bids)

No. Vol. Price($)
1 49999 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 16887 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.